Roth Capital revised its price target for Bio-Path Holdings Inc. (OTC:BPTH) to $2 from $9, while keeping a Buy rating on the ...

With offices in Nashville, TN and Charlottesville, VA, Iron Path Capital supports its partners with capital, operating expertise, business development, and industry relationships to achieve ...

However, we see a clear path to profitability ... these recent investments will allow the company to pull away from competitors. We expect research and development to stay relatively fixed ...

HOUSTON, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging ... of DNAbilize technology for development of a non-cancer application ...

Excitingly the deal significantly accelerates Mosaic’s development path, with the first clinical combination ... In-licensing transforms Mosaic from a research and platform company to a clinical-stage ...

This will be the second Hurley-owned building in the path of the bridge ... A statement from Hurley Development said the company purchased the substation site as a backup to build a new ...